Back to ADMA
Caligan Partners LP ADMA Position History
ADMA Biologics, Inc. • Healthcare
Quarters held
6
Latest value
$58.9M
Q3 2026
Peak value
$58.9M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $54.9M |
| Q1 2026 | $42.9M |
| Q1 2026 | $2.7M |
| Q2 2026 | $47.9M |
| Q2 2026 | $2.5M |
| Q3 2026 | $58.9M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $58.9M | 5.88M | — | — |
| Q2 2026 | $2.5M | 300.0K | — | — |
| Q2 2026 | $47.9M | 5.73M | — | — |
| Q1 2026 | $2.7M | 300.0K | — | — |
| Q1 2026 | $42.9M | 4.76M | — | — |
| Q4 2025 | $54.9M | 3.01M | — | — |
Other funds holding ADMA
$482.7M
$259.5M
$237.7M
$221.6M
$170.6M
$143.3M